B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Apixaban

an antithrombotic agent

997 PubMed studies analyzed · 245 RCTs · Evidence Score: 70.2

Research Domains

Apixaban has been studied across 11 research domains including ❤️ Cardiovascular, 🔬 Oncology, 🫘 Kidney, 🫁 Respiratory, 🦠 Gut & Microbiome. The primary research focus is ❤️ Cardiovascular with 87% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apixaban is generated deterministically from 997 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.